Throughout the years, EFCG has developed special relationships with a number of other industry associations to work on common issues. These include APIC – the Active Pharmaceutical Ingredients Committee, SOCMA – the US-based Society of Chemical Manufacturers and Affiliates, IPEC – the International Pharmaceutical Excipients Council, and the Rx-360 organisation on pharma supply chain security. In the last couple of years, we have further strengthened our relationship with those associations who represent manufacturers of agrochemical products and pharmaceutical final dosage forms - such as ECPA, EFPIA, EGA and AESGP - as well as with DG Sante, the Directorate-General for Health and Food Safety within the European Commission.
In order to achieve its mission EFCG is in regular contact with national and inter-governmental bodies such as European Commission, European Parliament, European Medicines Agency, European Directorate for the Quality of Medicines, US Food and Drug Administration, World Health Organisation, European Chemicals Agency, Permanent Representatives of Member States in Brussels.
In 2004 EFCG raised the first red flags about sub-standard Active Pharmaceutical Ingredients (APIs) entering Europe from India and China. Twelve years on, it appears that risks to patients from non-compliant bad quality APIs have been substantially reduced and that the playing field is levelling out.
EFCG Press Conference CPhI 2015: "API" day for Europe as Big Pharma returns in search of quality (by Dan Stanton)
EFCG Press Conference CPhI 2015: Outlook in Europe for API Manufacturers is positive, says EFCG